News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Drew Moghanaki: SAFRON II Was a “SABR in Lieu of Systemic Therapy” Study for Lung Metastases
Drew Moghanaki/LinkedIn
Jun 7, 2025, 12:39

Drew Moghanaki: SAFRON II Was a “SABR in Lieu of Systemic Therapy” Study for Lung Metastases

Drew Moghanaki, Chief Medical Officer at Respirati and Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology at David Geffen School of Medicine at UCLA, shared a post on X:

“Prof. Shankar Siva reminds us that SAFRON II was a ‘SABR in lieu of systemic therapy’ study for patients with lung metastases at SABRCAN 2025.”

Drew Moghanaki: SAFRON II Was a "SABR in Lieu of Systemic Therapy" Study for Lung Metastases

More posts featuring Drew Moghanaki.

cancer Drew Moghanaki OncoDaily Oncology SABR SABRCAN 2025 SAFRON II Shankar Siva
Special Coverage
Blog
Jun 7, 2025, 14:53
Amol Akhade Shared Treatment Algorithm for HR +/Her2 -mBC from ASCO25
Blog
Jun 7, 2025, 14:44
SPCC Will Host Webinar on Early Nutrition Screening and Intervention in Cancer Care
Insight
Jun 7, 2025, 14:38
Paolo Tarantino: Thanks to NSABP-B51, Countless Patients Will Be Spared the Toxicity of Nodal Irradiation
Blog
Jun 7, 2025, 14:12
Vinod Balachandran on Pancreatic Cancer and Its Prognosis - Memorial Sloan Kettering Cancer Center
Insight
Jun 7, 2025, 14:10
Childhood Cancer International Receives $50,000 Donation from MKA Group
Blog
Jun 7, 2025, 14:03
Nina Niu Sanford: The Simultaneous ASCO 2025 Presentation and Pubs Were Great
Blog
Jun 7, 2025, 13:44
Luis E. Raez: Florida CCRAB Meeting Focuses on New Florida Cancer Control Plan
Blog
Jun 7, 2025, 13:19
Caterina Sposetti: ASCO25 Was Filled With Science, Inspiration, and Meaningful Connections
Blog
Jun 7, 2025, 12:46
Alexandre Chan: Can a Team-based Approach Transform Cancer Survivorship Care?
Blog
Jun 7, 2025, 12:39
Drew Moghanaki: SAFRON II Was a "SABR in Lieu of Systemic Therapy" Study for Lung Metastases
Blog
Jun 7, 2025, 12:30
Adrelia Allen: ASCO25 Highlights - Meaningful Discussions on Clinical Trial Diversity
Blog
Jun 7, 2025, 12:23
Harold J. Burstein: So Much to Discuss About Breast Cancer After ASCO